Applied Therapeutics, Inc.
APLT
$0.5158
$0.00170.33%
NASDAQ
| 06/30/2025 | 03/31/2025 | 12/31/2024 | 09/30/2024 | 06/30/2024 | |
|---|---|---|---|---|---|
| Net Income | -21.33M | -21.83M | 44.01M | -68.59M | 2.90M |
| Total Depreciation and Amortization | 110.00K | 104.00K | 80.00K | 104.00K | 122.00K |
| Total Amortization of Deferred Charges | -- | -- | -- | -- | -- |
| Total Other Non-Cash Items | 565.00K | -1.71M | -69.04M | 42.17M | -20.80M |
| Change in Net Operating Assets | 314.00K | -5.20M | 5.49M | 2.99M | -4.81M |
| Cash from Operations | -20.34M | -28.64M | -19.47M | -23.33M | -22.60M |
| Capital Expenditure | -- | -- | -- | -- | -- |
| Sale of Property, Plant, and Equipment | -- | -- | -- | -- | -- |
| Cash Acquisitions | -- | -- | -- | -- | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | -- | -- | -- | -- | -- |
| Cash from Investing | -- | -- | -- | -- | -- |
| Total Debt Issued | -- | -- | -- | -- | -- |
| Total Debt Repaid | -- | -- | 0.00 | 0.00 | 0.00 |
| Issuance of Common Stock | -- | -- | 0.00 | 0.00 | -- |
| Repurchase of Common Stock | -- | -- | -- | -- | -1.69M |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | -- | -- | -- | -- | -- |
| Cash from Financing | -- | -- | 0.00 | 0.00 | -1.69M |
| Foreign Exchange rate Adjustments | -- | -- | -- | -- | -- |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | -20.34M | -28.64M | -19.47M | -23.33M | -24.29M |